The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...
The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...
Cytokinetics announced the FDA approval of aficamten to improve functional capacity and symptoms in adults with symptomatic ...
The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...
Not intended for UK audiences Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous ...
The FDA approved nerandomilast tablets for adults with progressive pulmonary fibrosis, according to an industry press release ...
Stocktwits on MSN
Cytokinetics wins first FDA approval for heart disease drug — why is Wall Street still cautious?
The drug is now expected to be available in the U.S. in the second half of January 2026. ・The prescribing information for the ...
Fesilty is supplied as a lyophilized powder for reconstitution in a single-dose vial containing approximately 1g of human fibrinogen.
Food and Drug Administration has approved Cytokinetics' drug to treat a rare heart condition, the company said on Friday.
Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...
With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback